London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
Oxford Nanopore Technologies
Dr. Gaia Nebbia
)
- Job title
- Institution
- Guy's and St Thomas' NHS Foundation Trust UK
- Biography
Dr. Gaia Nebbia, MBBSeq, MRCP, FRCPath, PhD, trained in virology and infectious diseases in London and completed her PhD in virology in 2008. Subsequently, she pursued further research in the field of viral immunology as an NIHR clinical lecturer. In 2015, Gaia joined Guy’s & St Thomas’ Hospital as a consultant virologist and in 2019, she was awarded the MRC Clinical Academic Research Partnerships grant to spearhead the development of real-time nanopore influenza sequencing and to conduct studies on influenza vaccine efficacy. Additionally, Gaia played a key role in implementing a whole-genome sequencing service for SARS-CoV-2 and respiratory metagenomics.
- Recent publications
Snell, L.B. et al. Real-time whole genome sequencing to guide patient-tailored therapy of severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 76(6):1125–1128 (2023). DOI: 10.1093/cid/ciac864
Williams, T.G.S. et al. Feasibility and clinical utility of local rapid nanopore influenza A virus whole genome sequencing for integrated outbreak management, genotypic resistance detection and timely surveillance. Microb Genom. 9(8) (2023). DOI: https://doi.org/10.1099/mgen.0.001083
Charalampous, T. et al. Routine metagenomics service for intensive care unit patients with respiratory infection. Am J Respir Crit Care Med. 209(2):164–174 (2023). DOI: 10.1164/rccm.202305-0901OC.
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)